Sign inJoin waitlistJoin the waitlist

Dennis Chi

Physician · Memorial Sloan Kettering Bergen

Credentials: · · ·

History

Memorial Sloan Kettering Bergen
2019–Present

Gynecologic Oncology
New York Presbyterian Hospital
1996–1999
Obstetrics and Gynecology
NYU Grossman School of Medicine
1992–1996
New York University
1986–1990

Research

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Gynecologic Oncology · 2006 · First of 10 authors · Corresponding · 487 citations
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · First of 10 authors · Corresponding · 474 citations
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
JAMA · 2000 · 403 citations

NA
Nadeem Abu-Rustum
206 papers · 2 as a fellow
YS
Yukio Sonoda
184 papers · 30 as a resident
RB
Richard Barakat
155 papers
Oliver Zivanovic
112 papers · 4 as a fellow
GG
Ginger Gardner
102 papers
ML
Mario Leitao
91 papers · 13 as a resident
KL
Kara Long
90 papers · 6 as a fellow
CA
Carol Aghajanian
64 papers
CB
Carol Brown
45 papers · 1 as a fellow
DL
Douglas Levine
45 papers · 9 as a fellow
RO
Roisin O'Cearbhaill
42 papers
Vance Broach
40 papers · 19 as a fellow

Clinical trials

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2024–2029
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2015–2022
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2013–2016
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2013–2025